272 related articles for article (PubMed ID: 35475667)
1. Impact of Micropolymorphism Outside the Peptide Binding Groove in the Clinically Relevant Allele HLA-C*14 on T Cell Responses in HIV-1 Infection.
Chikata T; Paes W; Kuse N; Partridge T; Gatanaga H; Zhang Y; Kuroki K; Maenaka K; Ternette N; Oka S; Borrow P; Takiguchi M
J Virol; 2022 May; 96(10):e0043222. PubMed ID: 35475667
[TBL] [Abstract][Full Text] [Related]
2. Identification of Immunodominant HIV-1 Epitopes Presented by HLA-C*12:02, a Protective Allele, Using an Immunopeptidomics Approach.
Chikata T; Paes W; Akahoshi T; Partridge T; Murakoshi H; Gatanaga H; Ternette N; Oka S; Borrow P; Takiguchi M
J Virol; 2019 Sep; 93(17):. PubMed ID: 31217245
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
[TBL] [Abstract][Full Text] [Related]
4. Immunological Control of HIV-1 Disease Progression by Rare Protective HLA Allele.
Zhang Y; Chikata T; Kuse N; Murakoshi H; Gatanaga H; Oka S; Takiguchi M
J Virol; 2022 Nov; 96(22):e0124822. PubMed ID: 36326273
[TBL] [Abstract][Full Text] [Related]
5. Differential Immunodominance Hierarchy of CD8
Adland E; Hill M; Lavandier N; Csala A; Edwards A; Chen F; Radkowski M; Kowalska JD; Paraskevis D; Hatzakis A; Valenzuela-Ponce H; Pfafferott K; Williams I; Pellegrino P; Borrow P; Mori M; Rockstroh J; Prado JG; Mothe B; Dalmau J; Martinez-Picado J; Tudor-Williams G; Frater J; Stryhn A; Buus S; Teran GR; Mallal S; John M; Buchbinder S; Kirk G; Martin J; Michael N; Fellay J; Deeks S; Walker B; Avila-Rios S; Cole D; Brander C; Carrington M; Goulder P
J Virol; 2018 Feb; 92(4):. PubMed ID: 29167337
[TBL] [Abstract][Full Text] [Related]
6. HLA-B*57 Micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure, and HIV immune control.
Kloverpris HN; Stryhn A; Harndahl M; van der Stok M; Payne RP; Matthews PC; Chen F; Riddell L; Walker BD; Ndung'u T; Buus S; Goulder P
J Virol; 2012 Jan; 86(2):919-29. PubMed ID: 22090105
[TBL] [Abstract][Full Text] [Related]
7. Control of HIV-1 Replication by CD8
Nguyen HT; Kuse N; Zhang Y; Murakoshi H; Maeda Y; Tamura Y; Maruyama R; Tran GV; Nguyen TV; Nguyen KV; Oka S; Chikata T; Takiguchi M
J Virol; 2022 Oct; 96(19):e0081122. PubMed ID: 36154612
[TBL] [Abstract][Full Text] [Related]
8. Contribution of proteasome-catalyzed peptide
Paes W; Leonov G; Partridge T; Chikata T; Murakoshi H; Frangou A; Brackenridge S; Nicastri A; Smith AG; Learn GH; Li Y; Parker R; Oka S; Pellegrino P; Williams I; Haynes BF; McMichael AJ; Shaw GM; Hahn BH; Takiguchi M; Ternette N; Borrow P
Proc Natl Acad Sci U S A; 2019 Dec; 116(49):24748-24759. PubMed ID: 31748275
[TBL] [Abstract][Full Text] [Related]
9. HIV-1-specific cytotoxic T lymphocyte (CTL) responses against immunodominant optimal epitopes slow the progression of AIDS in China.
Zhai S; Zhuang Y; Song Y; Li S; Huang D; Kang W; Li X; Liao Q; Liu Y; Zhao Z; Lu Y; Sun Y
Curr HIV Res; 2008 Jun; 6(4):335-50. PubMed ID: 18691032
[TBL] [Abstract][Full Text] [Related]
10. Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8
Karimzadeh H; Kiraithe MM; Kosinska AD; Glaser M; Fiedler M; Oberhardt V; Salimi Alizei E; Hofmann M; Mok JY; Nguyen M; van Esch WJE; Budeus B; Grabowski J; Homs M; Olivero A; Keyvani H; Rodríguez-Frías F; Tabernero D; Buti M; Heinold A; Alavian SM; Bauer T; Schulze Zur Wiesch J; Raziorrouh B; Hoffmann D; Smedile A; Rizzetto M; Wedemeyer H; Timm J; Antes I; Neumann-Haefelin C; Protzer U; Roggendorf M
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669837
[TBL] [Abstract][Full Text] [Related]
11. Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines.
Borthwick N; Lin Z; Akahoshi T; Llano A; Silva-Arrieta S; Ahmed T; Dorrell L; Brander C; Murakoshi H; Takiguchi M; Hanke T
PLoS One; 2017; 12(4):e0176418. PubMed ID: 28448594
[TBL] [Abstract][Full Text] [Related]
12. STING Ligand-Mediated Priming of Functional CD8
Kuse N; Akahoshi T; Takiguchi M
J Virol; 2021 Jul; 95(16):e0069921. PubMed ID: 34076478
[TBL] [Abstract][Full Text] [Related]
13. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of HIV-1 epitopes presented by HLA-A*2603: comparison between HIV-1 epitopes presented by A*2601 and A*2603.
Kawashima Y; Satoh M; Oka S; Takiguchi M
Hum Immunol; 2005 Nov; 66(11):1155-66. PubMed ID: 16571416
[TBL] [Abstract][Full Text] [Related]
15. Effective recognition of HIV-1-infected cells by HIV-1 integrase-specific HLA-B∗4002-restricted T cells.
Watanabe T; Murakoshi H; Gatanaga H; Koyanagi M; Oka S; Takiguchi M
Microbes Infect; 2011 Feb; 13(2):160-6. PubMed ID: 20971209
[TBL] [Abstract][Full Text] [Related]
16. CD8
Murakoshi H; Zou C; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
Retrovirology; 2018 Jul; 15(1):46. PubMed ID: 29970102
[TBL] [Abstract][Full Text] [Related]
17. High-avidity, high-IFNγ-producing CD8 T-cell responses following immune selection during HIV-1 infection.
Keane NM; Roberts SG; Almeida CA; Krishnan T; Chopra A; Demaine E; Laird R; Tschochner M; Carlson JM; Mallal S; Heckerman D; James I; John M
Immunol Cell Biol; 2012 Feb; 90(2):224-34. PubMed ID: 21577229
[TBL] [Abstract][Full Text] [Related]
18. A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected Thais.
Buranapraditkun S; Hempel U; Pitakpolrat P; Allgaier RL; Thantivorasit P; Lorenzen SI; Sirivichayakul S; Hildebrand WH; Altfeld M; Brander C; Walker BD; Phanuphak P; Hansasuta P; Rowland-Jones SL; Allen TM; Ruxrungtham K
PLoS One; 2011; 6(8):e23603. PubMed ID: 21887282
[TBL] [Abstract][Full Text] [Related]
19. HLA-A*7401-mediated control of HIV viremia is independent of its linkage disequilibrium with HLA-B*5703.
Matthews PC; Adland E; Listgarten J; Leslie A; Mkhwanazi N; Carlson JM; Harndahl M; Stryhn A; Payne RP; Ogwu A; Huang KH; Frater J; Paioni P; Kloverpris H; Jooste P; Goedhals D; van Vuuren C; Steyn D; Riddell L; Chen F; Luzzi G; Balachandran T; Ndung'u T; Buus S; Carrington M; Shapiro R; Heckerman D; Goulder PJ
J Immunol; 2011 May; 186(10):5675-86. PubMed ID: 21498667
[TBL] [Abstract][Full Text] [Related]
20. Targeting of a CD8 T cell env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure.
Ngumbela KC; Day CL; Mncube Z; Nair K; Ramduth D; Thobakgale C; Moodley E; Reddy S; de Pierres C; Mkhwanazi N; Bishop K; van der Stok M; Ismail N; Honeyborne I; Crawford H; Kavanagh DG; Rousseau C; Nickle D; Mullins J; Heckerman D; Korber B; Coovadia H; Kiepiela P; Goulder PJ; Walker BD
AIDS Res Hum Retroviruses; 2008 Jan; 24(1):72-82. PubMed ID: 18275350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
